Breakpoint mapping of a t(9;22;12) chronic myeloid leukaemia patient with e14a3 BCR‐ABL1 transcript using Nanopore sequencing
Authors:
- 19 September 2020
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 23 (1) , e3276
Abstract
Background: The genetic changes in chronic myeloid leukaemia (CML) have been well established, although challenges persist in cases with rare fusion transcripts or complex variant translocations. Here, we present a CML patient with e14a3 BCR‐ABL1 transcript and t(9;22;12) variant Philadelphia (Ph) chromosome.Methods: Cytogenetic analysis and fluorescence in situ hybridization (FISH) was performed to identify the chromosomal aberrations and gene fusions. Rare fusion transcript was verified by a reverse transcription‐polymerase chain reaction (RT‐PCR). Breakpoints were characterized and validated using Oxford Nanopore Technologies (ONT) (Oxford, UK) and Sanger sequencing, respectively.Results: The karyotype showed the translocation t(9;22;12)(q34;q11.2;q24) [20] and FISH indicated 40% positive BCR‐ABL1 fusion signals. The RT‐PCR suggested e14a3 type fusion transcript. The ONT sequencing analysis identified specific positions of translocation breakpoints: chr22:23633040–chr9:133729579, chr12:121567595–chr22:24701405, which were confirmed using Sanger sequencing. The patient achieved molecular remission 3 months after imatinib therapy.Conclusions: The present study indicates Nanopore sequencing as a valid strategy, which can characterize breakpoints precisely in special clinical cases with atypical structural variations. CML patients with e14a3 transcripts may have good clinical course in the tyrosine kinase inhibitor era, as reviewed here.Keywords
This publication has 55 references indexed in Scilit:
- Evidence for Transcript Networks Composed of Chimeric RNAs in Human CellsPLOS ONE, 2012
- Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysisBlood, 2011
- CNVnator: An approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencingGenome Research, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- Assembly of large genomes using second-generation sequencingGenome Research, 2010
- Sequencing technologies — the next generationNature Reviews Genetics, 2009
- A Rare e14a3 (b3a3) BCR-ABL Fusion Transcript in Chronic Myeloid LeukemiaThe Journal of Molecular Diagnostics, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG‐richest regions of the genomeGenes, Chromosomes and Cancer, 2005